The impact of hepatitis C virus infection on long-term outcome in renal transplant patients

Turkish Journal of Gastroenterology

Volumn 22, Issue 2, 2011, Pages 165-170

  Ruhi, Çaǧlar ^a   Süleymanlar, Inci ^a   Koçak, Hüseyin ^a   Yilmaz, Vural Taner ^a   Çolak, Dilek ^a   Dinçkan, Ayhan ^a   Gürkan, Alihan ^a   Ersoy, Fevzi ^a   Yakupoǧlu, Gülşen ^a   Süleymanlar, Gültekin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

End stage renal disease; Hepatitis C virus infection; Long term survival; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLOSPORIN A; HEPATITIS C ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SEX DIFFERENCE;

FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; MALE; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79960212961     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2011.0236     Document Type: Article

References (28)

1. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51: 981-99. (Pubitemid 27186522)
2. [No authors listed]. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008; 73(Suppl): S1-S99.
3. Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000; 11: 1343-53. (Pubitemid 30416233)
4. Serdengeçti K, Süleymanlar G, Altiparmak MR, Seyahi N. Registry of the Nephrology Dialysis and Transplantation in Turkey (Registry-2008). Istanbul: Turkish Society of Nephrology, 2009.
5. Pereira BJ, Natov SN, Bouthot BA, et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998; 53: 1374-81. (Pubitemid 28316901)
6. Knoll GA, Tankersley MR, Lee JY, et al. The impact of renal transplantation on survival in hepatitis C-positive endstage renal disease patients. Am J Kidney Dis 1997; 29: 608-14. (Pubitemid 27155284)
7. Fabrizi F, Martin P, Dixit V, et al. Hepatitis C virus antibody status and survival after renal transplantation: metaanalysis of observational studies. Am J Transplant 2005; 5: 1452.
8. Rao KV, Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765.
9. Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667.
10. Breitenfeldt MK, Rasenack J, Berthold H, et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002; 16: 130-6. (Pubitemid 34414061)
11. Sezer S, Ozdemir FN, Akcay A, et al. Renal transplantation offers a better survival in HCV infected ESRD patients. Clin Transplant 2004; 18: 619-23. (Pubitemid 39264364)
12. Meier-Kriesche HU, Ojo AO, Hanson JA, et al. Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation 2001; 72: 241-4.
13. Kliem V, van den Hoff U, Brunkhorst R, et al. The longterm course of hepatitis C after kidney transplantation. Transplantation 1996; 62: 1417-21. (Pubitemid 26404662)
14. Kamar N, Rostaing L, Selves J, et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005; 5: 1704-12. (Pubitemid 40910453)
15. Watashi K, Hijikata M, Hosaka M, et al. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003; 38: 1282-8. (Pubitemid 37314838)
16. Luan FL, Schaubel DE, Zhang H, et al. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation 2008; 85(11): 1601-6.
17. Rostaing L, Izopet J, Sandres K, et al. Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil. Transplantation 2000; 69: 991-4. (Pubitemid 30174134)
18. Kornberg A, Kupper B, Tannapfel A, et al. Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation. Int Immunopharmacol 2005; 5: 107-15. (Pubitemid 39626692)
19. Fasola CG, Netto GJ, Christensen LL, et al. Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction. Transplant Proc 2002; 34: 1561-2.
20. Stempel CA, Lake J, Kuo G, et al. Hepatitis C - its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273-6. (Pubitemid 23065453)
21. Cosio FG, Roche Z, Agarwal A, et al. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996; 28: 752- 8.
22. Santos L, Alves R, Macario F, et al. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience. Transplant Proc 2009; 41: 880-2.
23. Forman JP, Tolkoff-Rubin N, Pascual M, et al. Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol 2004; 15: 3249-55. (Pubitemid 39578858)
24. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-85. (Pubitemid 36323115)
25. Kliem V, Burg M, Haller H. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data. Transplant Proc 2008; 40: 909-14. (Pubitemid 351802226)
26. Narula AS, Hooda A, Anand AC, et al. Impact of hepatitis C virus infection in renal transplant recipients. Indian J Gastroenterol 2005; 24: 151-4. (Pubitemid 41391995)
27. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-63. (Pubitemid 29024011)
28. Hanafusa T, Ichikawa Y, Kishikawa H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471-6. (Pubitemid 28415373)